Drug Type Antisense oligonucleotides |
Synonyms QRX 323, QRX323 |
Target |
Mechanism COL7A1 exon 80 inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epidermolysis Bullosa | Preclinical | NL | 19 Dec 2018 |